Company news

Proteomics International Laboratories Ltd. news in 2021

Proteomics International Laboratories Ltd.'s news releases, calls and decks from 2021, newest first.

View company

Proteomics secures major pharmacokinetic testing contract

December 15, 2021

Proteomics receives $1.2 million in R&D tax incentive

December 13, 2021

PromarkerD distribution network expands to Britain

November 22, 2021

PromarkerD outperforms standard of care tests for DKD

November 4, 2021

Proteomics awarded $100,000 manufacturing funding

November 2, 2021

September 2021 Quarterly Activities Report and Appendix 4C

October 27, 2021

Clinical utility study shows benefit of PromarkerD testing

October 17, 2021

Proteomics contracts Biotem to manufacture PromarkerD kits

August 11, 2021

Proteomics to collaborate to validate test for endometriosis

August 3, 2021

June 2021 Quarterly Activities Report and Appendix 4C

July 29, 2021

Proteomics engages Abcam to manufacture PromarkerD reagents

July 21, 2021

Study shows diabetes drug improves PromarkerD risk scores

July 15, 2021

Reinstatement to Official Quotation

July 2, 2021

Suspension from Official Quotation

June 29, 2021

Modelling shows PromarkerD could save US payers $384 billion

June 24, 2021

Proteomics secures major analytical services contract

May 17, 2021

Major economic health benefit demonstrated for PromarkerD

May 12, 2021

March 2021 Quarterly Activities Report and Appendix 4C

April 28, 2021

ISO 13485 certification received - Manufacturing Update

April 22, 2021

Response to Price Query

February 16, 2021

Proteomics International seeks FDA approval for PromarkerD

February 7, 2021

December 2020 Quarterly Activities Report and Appendix 4C

January 27, 2021

Decks in 2021